Redeye initiates coverage of Stille, a high-quality producer of surgical instruments and operation tables set to rebound. The company offers a steady growth play supported by current healthcare trends. Future M&A-activity and leveraging its strong sales channels should lift the share, which trades at a notable discount to fair value.